INCONTESTABLE® Blog
April 19, 2024
Webinar
Advertising Self-Regulation in 2024: Q&A with NAD Vice President Laura Brett
January 30, 2024
Never miss an Insight.
Sign upIP Health Blog
FDA Draft Guidance on Evaluation of Therapeutic Equivalence FDA Draft Guidance on Evaluation of Therapeutic Equivalence
August 4, 2022
IP Health Blog
Final FDA Guidance on Safety Considerations for Medication Container Labels and Carton Labeling Final FDA Guidance on Safety Considerations for Medication Container Labels and Carton Labeling
June 10, 2022
Books
Intellectual Property in the Energy Sector: Challenges and Opportunities for an Industry in Transition Intellectual Property in the Energy Sector: Challenges and Opportunities for an Industry in Transition
June 2022
Globe Law and BusinessEvent
Patent Inventorship: Best Practices for Determination and Correction Patent Inventorship: Best Practices for Determination and Correction
May 5, 2022
Articles
Driving Forward: The Automotive Tech Fuelling IP Interests Driving Forward: The Automotive Tech Fuelling IP Interests
April 5, 2022
Managing Intellectual PropertyArticles
The Road Ahead – IP Challenges in the Automotive Industry The Road Ahead – IP Challenges in the Automotive Industry
February 9, 2022
Managing Intellectual PropertyIP Health Blog
FDA Final Guidance on Enhancing the Diversity of Clinical Trial Populations FDA Final Guidance on Enhancing the Diversity of Clinical Trial Populations
November 19, 2020
IP Health Blog
FDA Draft Guidance on the Orange Book - Questions and Answers FDA Draft Guidance on the Orange Book - Questions and Answers
June 8, 2020
Articles
A New Guide for Promotional Labeling and Advertising of Biosimilar Products A New Guide for Promotional Labeling and Advertising of Biosimilar Products
May 26, 2020
Biosimilar DevelopmentDue to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.